A new European white paper has put the spotlight on Inflammatory Neuropathies and, reading it, we found ourselves thinking, "We've been saying this for years."

The interim findings from the government's Timms Review into Personal Independence Payments (PIP) are out, but what do they mean for people impacted by Inflammatory Neuropathies

Community means something different to different people. This isn't an argument against place based communities, it's an argument against forgetting communities of interest

Our new Impact Report is out now. But what does it mean, what have we done, and what are we doing.

Why do we respond to public consultations. Because you need to be heard.

We had some excellent results from the My Neuro Survey findings, but we wanted to dig deeper.

This year, we made the decision to attend the Association of British Neurologists Conference. On paper, it’s a professional gathering of experts. But for us at Inflammatory Neuropathies UK, it’s something much more human than that. It’s all about people, and more specifically our Community. People who are living with rare, often misunderstood conditions. People who may still be searching for a diagnosis. People who don’t yet know that support, information and community exist

Every May, something powerful happens. Across the UK and beyond, people impacted by Inflammatory Neuropathies all look to raise awareness and talk about their condition.  GBS and CIDP Awareness Month isn’t just a date in the calendar for us at Inflammatory Neuropathies UK. It’s one of the few moments in the year where our whole community (people living with conditions like Guillain-Barré syndrome (GBS), CIDP, and other Inflammatory Neuropathies, along with their families, cli

Yesterday, NHS England published a new service specification for Adult Neurology Services. Our Chief Executive, Rich Collins, fed back...

We've been talking about Peer Support for GBS, CIDP, MMN, and the other conditions we support at the Inflammatory Neuropathies UK office....

Obviously, the advice from the MHRA is concerning. We would always be worried about any increased risk of Guillain-Barré Syndrome for...

So, after much consultation, feedback, and discussion, the government today released its new 10 year plan. Here at Inflammatory...

Inflammatory Neuropathies UK's Chief Executive, Rich Collins, on our rebrand: Well, this is very big news. GAIN is changing its name to...